OpenAI, PerturbAI and Scripps deploy thousands of AI agents to find drug leads in brain cell data

OpenAI partnered with biotech startup PerturbAI and Scripps Research to deploy thousands of AI agents to analyze brain cell data at scale. The agents worked in parallel to process information from millions of individual cells, identifying promising research leads that human researchers might have missed or taken far longer to find. The approach demonstrates how distributed AI systems can tackle complex scientific problems by breaking them into smaller tasks and coordinating across many agents.